Black Diamond Therapeutics, Inc. (BDTX) SEC Filings — 2025
8 SEC filings for Black Diamond Therapeutics, Inc. (BDTX) in 2025.
Filings
- Black Diamond Therapeutics, Inc. 8-K Filing — 8-K · Dec 3, 2025
- BDTX Swings to Profit on $70M License Revenue, R&D Costs Down — 10-Q · Nov 6, 2025
- BDTX Losses Widen Amid Increased R&D Spend, Cash Burn Continues — 10-Q · Aug 7, 2025
- Black Diamond Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 12, 2025
- Black Diamond Therapeutics Files Q1 2025 10-Q — 10-Q · May 12, 2025
- Black Diamond Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 18, 2025
- Black Diamond Therapeutics Enters Material Definitive Agreement — 8-K · Mar 19, 2025
- Black Diamond Therapeutics Files 2024 10-K — 10-K · Mar 6, 2025